Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial (Q41551275)

3 October 2017

title

Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial (English)

1 reference

3 October 2017

0 references

1 reference

Dara A Charney

1

1 reference

3 October 2017

Laura M Heath

2

1 reference

3 October 2017

Eugenia Zikos

3

1 reference

3 October 2017

Jorge Palacios-Boix

4

1 reference

3 October 2017

Kathryn J Gill

5

1 reference

3 October 2017

publication date

24 July 2015

1 reference

Alcoholism: Clinical and Experimental Research

3 October 2017

published in

1 reference

3 October 2017

volume

39

1 reference

3 October 2017

issue

9

1 reference

3 October 2017

page(s)

1756-1765

1 reference

Interviewer severity ratings and composite scores of the ASI: a further look.

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Association between concurrent depression and anxiety and six-month outcome of addiction treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Coefficient alpha and the internal structure of tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Effects of fluvoxamine on a multiple schedule of ethanol- and food-maintained behavior in two rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

The effect of depression on return to drinking: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Missing data in alcohol clinical trials: a comparison of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Sertraline treatment of co-occurring alcohol dependence and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Current status of co-occurring mood and substance use disorders: a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Double-blind clinical trial of sertraline treatment for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACER.12802

21 January 2018

Identifiers

DOI

10.1111/ACER.12802

1 reference

3 October 2017

1 reference